RxDoctor Payments Data

Adam Turnock, MD

MOHS-Micrographic Surgery · Tucson, AZNPI 1720510431

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Genentech USA, Inc. at 35.7% of the total. Reporting peaked in 2024 at $161 and has fallen 77.8% since, to $36 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in AZ, where the typical reported total is $1,522.

$692in general payments, 2019–2025

Across 23 payments — averaging $30.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$247
  • Sanofi$159
  • Johnson & Johnson$120
  • Sun Pharmaceutical Industries Inc.$47
  • Novartis$26
  • Lilly USA, LLC$24
  • plus $69 from 4 others

What the payments were for

  • Food & beverage$692100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$692 in reported general payments places this provider in the 25th percentile of 38 mohs-micrographic surgery providers in Arizona.

See all mohs-micrographic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$793,957
Medicare patients
700
Services billed
2,282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate132$5,097
Fluorouracil43$3,261
Cephalexin164$1,500
Mupirocin136$1,116
Acetaminophen-CodeineAcetaminophen With Codeine64$341
Doxycycline Hyclate12$98

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →